MEHCQNYSEdelisted
Chrome Holding Co.
Healthcare·Healthcare
5.0/10
BioSniper Score
3-factor signal
Market Cap
—
Cash Runway
6.1 mo
Lead Asset
gsk2023
Next Catalyst
—
Chrome Holding Co.: 1 pipeline candidate · Updated within the last hour.
Go deeper on Chrome Holding Co. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on MEHCQ — live, with citations.
Score breakdown3-factor signal · derived from public data
Cash Runway1.7
6.1 months
Financial Health10.0
D/E -4.37
Pipeline MaturityN/A
N/A
Pipeline Breadth3.3
1 candidate
Catalyst MomentumN/A
N/A
Insider SignalN/A
N/A
Key Financialsas of June 30, 2025
Cash
$45.6M
Quarterly Burn
$29.0M
Revenue
$25.4M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Cash ends ~Dec 2026
Today~7 mo out
Catalyst within runway
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| gsk2023 | — |
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Chrome Holding Co.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.